Changes in low-Km cAMP phosphodiesterase activity in liver Golgi fractions from hyper- and hypoinsulinemic rats. Diabetes June 1988 37:717-722; doi:10.2337/diabetes.37.6.717
Circulating levels and bone contents of bone gamma-carboxyglutamic acid-containing protein are decreased in streptozocin-induced
diabetes. Possible marker for diabetic osteopenia. Diabetes June 1988 37:702-706; doi:10.2337/diabetes.37.6.702
Insulin directly reduces platelet sensitivity to aggregating agents. Studies in vitro and in vivo. Diabetes June 1988 37:780-786; doi:10.2337/diabetes.37.6.780
Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes June 1988 37:832-837; doi:10.2337/diabetes.37.6.832
Insulin action and insulin secretion in identical twins with MODY. Evidence for defects in both insulin action and secretion.
Diabetes June 1988 37:730-735; doi:10.2337/diabetes.37.6.730
Reduction of glycemic potentiation. Sensitive indicator of beta-cell loss in partially pancreatectomized dogs. Diabetes June 1988 37:723-729; doi:10.2337/diabetes.37.6.723
Insulin action and insulin secretion in identical twins with MODY. Evidence for defects in both insulin action and secretion.
Diabetes June 1988 37:730-735; doi:10.2337/diabetes.37.6.730
Changes in low-Km cAMP phosphodiesterase activity in liver Golgi fractions from hyper- and hypoinsulinemic rats. Diabetes June 1988 37:717-722; doi:10.2337/diabetes.37.6.717
Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious
dogs. Diabetes June 1988 37:749-759; doi:10.2337/diabetes.37.6.749
Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes June 1988 37:736-744; doi:10.2337/diabetes.37.6.736
Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious
dogs. Diabetes June 1988 37:749-759; doi:10.2337/diabetes.37.6.749
Insulin directly reduces platelet sensitivity to aggregating agents. Studies in vitro and in vivo. Diabetes June 1988 37:780-786; doi:10.2337/diabetes.37.6.780
Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious
dogs. Diabetes June 1988 37:749-759; doi:10.2337/diabetes.37.6.749
Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes June 1988 37:736-744; doi:10.2337/diabetes.37.6.736
Two-color flow cytometry analysis of activated T-lymphocyte subsets in type I diabetes mellitus. Diabetes June 1988 37:792-795; doi:10.2337/diabetes.37.6.792
Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes June 1988 37:667-687
Desbuquois, B
Changes in low-Km cAMP phosphodiesterase activity in liver Golgi fractions from hyper- and hypoinsulinemic rats. Diabetes June 1988 37:717-722; doi:10.2337/diabetes.37.6.717
Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious
dogs. Diabetes June 1988 37:749-759; doi:10.2337/diabetes.37.6.749
Insulin directly reduces platelet sensitivity to aggregating agents. Studies in vitro and in vivo. Diabetes June 1988 37:780-786; doi:10.2337/diabetes.37.6.780
Insulin action and insulin secretion in identical twins with MODY. Evidence for defects in both insulin action and secretion.
Diabetes June 1988 37:730-735; doi:10.2337/diabetes.37.6.730
Genetic analysis of glucose tolerance in inbred mouse strains. Evidence for polygenic control. Diabetes June 1988 37:707-713; doi:10.2337/diabetes.37.6.707
Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious
dogs. Diabetes June 1988 37:749-759; doi:10.2337/diabetes.37.6.749
Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious
dogs. Diabetes June 1988 37:749-759; doi:10.2337/diabetes.37.6.749
Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy?
Diabetes June 1988 37:688-693; doi:10.2337/diabetes.37.6.688
Two-color flow cytometry analysis of activated T-lymphocyte subsets in type I diabetes mellitus. Diabetes June 1988 37:792-795; doi:10.2337/diabetes.37.6.792
Circulating levels and bone contents of bone gamma-carboxyglutamic acid-containing protein are decreased in streptozocin-induced
diabetes. Possible marker for diabetic osteopenia. Diabetes June 1988 37:702-706; doi:10.2337/diabetes.37.6.702
Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious
dogs. Diabetes June 1988 37:749-759; doi:10.2337/diabetes.37.6.749
Maintenance of high-energy brain phosphorous compounds during insulin-induced hypoglycemia in men. 31P nuclear magnetic resonance
spectroscopy study. Diabetes June 1988 37:760-762; doi:10.2337/diabetes.37.6.760
Maintenance of high-energy brain phosphorous compounds during insulin-induced hypoglycemia in men. 31P nuclear magnetic resonance
spectroscopy study. Diabetes June 1988 37:760-762; doi:10.2337/diabetes.37.6.760
Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes June 1988 37:832-837; doi:10.2337/diabetes.37.6.832
Taste-induced changes in plasma insulin and glucose turnover in lean and genetically obese rats. Diabetes June 1988 37:773-779; doi:10.2337/diabetes.37.6.773
Circulating levels and bone contents of bone gamma-carboxyglutamic acid-containing protein are decreased in streptozocin-induced
diabetes. Possible marker for diabetic osteopenia. Diabetes June 1988 37:702-706; doi:10.2337/diabetes.37.6.702
Taste-induced changes in plasma insulin and glucose turnover in lean and genetically obese rats. Diabetes June 1988 37:773-779; doi:10.2337/diabetes.37.6.773
Maintenance of high-energy brain phosphorous compounds during insulin-induced hypoglycemia in men. 31P nuclear magnetic resonance
spectroscopy study. Diabetes June 1988 37:760-762; doi:10.2337/diabetes.37.6.760
Genetic analysis of glucose tolerance in inbred mouse strains. Evidence for polygenic control. Diabetes June 1988 37:707-713; doi:10.2337/diabetes.37.6.707
Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes June 1988 37:736-744; doi:10.2337/diabetes.37.6.736
Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious
dogs. Diabetes June 1988 37:749-759; doi:10.2337/diabetes.37.6.749
Maintenance of high-energy brain phosphorous compounds during insulin-induced hypoglycemia in men. 31P nuclear magnetic resonance
spectroscopy study. Diabetes June 1988 37:760-762; doi:10.2337/diabetes.37.6.760
Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy?
Diabetes June 1988 37:688-693; doi:10.2337/diabetes.37.6.688
Two-color flow cytometry analysis of activated T-lymphocyte subsets in type I diabetes mellitus. Diabetes June 1988 37:792-795; doi:10.2337/diabetes.37.6.792
Changes in low-Km cAMP phosphodiesterase activity in liver Golgi fractions from hyper- and hypoinsulinemic rats. Diabetes June 1988 37:717-722; doi:10.2337/diabetes.37.6.717
Insulin directly reduces platelet sensitivity to aggregating agents. Studies in vitro and in vivo. Diabetes June 1988 37:780-786; doi:10.2337/diabetes.37.6.780
Evidence for two independent pathways of insulin-receptor internalization in hepatocytes and hepatoma cells. Diabetes June 1988 37:806-815; doi:10.2337/diabetes.37.6.806
Circulating levels and bone contents of bone gamma-carboxyglutamic acid-containing protein are decreased in streptozocin-induced
diabetes. Possible marker for diabetic osteopenia. Diabetes June 1988 37:702-706; doi:10.2337/diabetes.37.6.702
Insulin directly reduces platelet sensitivity to aggregating agents. Studies in vitro and in vivo. Diabetes June 1988 37:780-786; doi:10.2337/diabetes.37.6.780
Insulin action and insulin secretion in identical twins with MODY. Evidence for defects in both insulin action and secretion.
Diabetes June 1988 37:730-735; doi:10.2337/diabetes.37.6.730
Evidence for two independent pathways of insulin-receptor internalization in hepatocytes and hepatoma cells. Diabetes June 1988 37:806-815; doi:10.2337/diabetes.37.6.806
Insulin action and insulin secretion in identical twins with MODY. Evidence for defects in both insulin action and secretion.
Diabetes June 1988 37:730-735; doi:10.2337/diabetes.37.6.730
Genetic analysis of glucose tolerance in inbred mouse strains. Evidence for polygenic control. Diabetes June 1988 37:707-713; doi:10.2337/diabetes.37.6.707
Reduction of glycemic potentiation. Sensitive indicator of beta-cell loss in partially pancreatectomized dogs. Diabetes June 1988 37:723-729; doi:10.2337/diabetes.37.6.723
Taste-induced changes in plasma insulin and glucose turnover in lean and genetically obese rats. Diabetes June 1988 37:773-779; doi:10.2337/diabetes.37.6.773
Genetic analysis of glucose tolerance in inbred mouse strains. Evidence for polygenic control. Diabetes June 1988 37:707-713; doi:10.2337/diabetes.37.6.707
Taste-induced changes in plasma insulin and glucose turnover in lean and genetically obese rats. Diabetes June 1988 37:773-779; doi:10.2337/diabetes.37.6.773
Taste-induced changes in plasma insulin and glucose turnover in lean and genetically obese rats. Diabetes June 1988 37:773-779; doi:10.2337/diabetes.37.6.773
Two-color flow cytometry analysis of activated T-lymphocyte subsets in type I diabetes mellitus. Diabetes June 1988 37:792-795; doi:10.2337/diabetes.37.6.792
Insulin action and insulin secretion in identical twins with MODY. Evidence for defects in both insulin action and secretion.
Diabetes June 1988 37:730-735; doi:10.2337/diabetes.37.6.730
Circulating levels and bone contents of bone gamma-carboxyglutamic acid-containing protein are decreased in streptozocin-induced
diabetes. Possible marker for diabetic osteopenia. Diabetes June 1988 37:702-706; doi:10.2337/diabetes.37.6.702
Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy?
Diabetes June 1988 37:688-693; doi:10.2337/diabetes.37.6.688
Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious
dogs. Diabetes June 1988 37:749-759; doi:10.2337/diabetes.37.6.749
Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes. Diabetes June 1988 37:736-744; doi:10.2337/diabetes.37.6.736
Reduction of glycemic potentiation. Sensitive indicator of beta-cell loss in partially pancreatectomized dogs. Diabetes June 1988 37:723-729; doi:10.2337/diabetes.37.6.723
Circulating levels and bone contents of bone gamma-carboxyglutamic acid-containing protein are decreased in streptozocin-induced
diabetes. Possible marker for diabetic osteopenia. Diabetes June 1988 37:702-706; doi:10.2337/diabetes.37.6.702
Circulating levels and bone contents of bone gamma-carboxyglutamic acid-containing protein are decreased in streptozocin-induced
diabetes. Possible marker for diabetic osteopenia. Diabetes June 1988 37:702-706; doi:10.2337/diabetes.37.6.702
Maintenance of high-energy brain phosphorous compounds during insulin-induced hypoglycemia in men. 31P nuclear magnetic resonance
spectroscopy study. Diabetes June 1988 37:760-762; doi:10.2337/diabetes.37.6.760
Insulin directly reduces platelet sensitivity to aggregating agents. Studies in vitro and in vivo. Diabetes June 1988 37:780-786; doi:10.2337/diabetes.37.6.780
Circulating levels and bone contents of bone gamma-carboxyglutamic acid-containing protein are decreased in streptozocin-induced
diabetes. Possible marker for diabetic osteopenia. Diabetes June 1988 37:702-706; doi:10.2337/diabetes.37.6.702
Circulating levels and bone contents of bone gamma-carboxyglutamic acid-containing protein are decreased in streptozocin-induced
diabetes. Possible marker for diabetic osteopenia. Diabetes June 1988 37:702-706; doi:10.2337/diabetes.37.6.702
Reduction of glycemic potentiation. Sensitive indicator of beta-cell loss in partially pancreatectomized dogs. Diabetes June 1988 37:723-729; doi:10.2337/diabetes.37.6.723
Reduction of glycemic potentiation. Sensitive indicator of beta-cell loss in partially pancreatectomized dogs. Diabetes June 1988 37:723-729; doi:10.2337/diabetes.37.6.723
Two-color flow cytometry analysis of activated T-lymphocyte subsets in type I diabetes mellitus. Diabetes June 1988 37:792-795; doi:10.2337/diabetes.37.6.792
Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious
dogs. Diabetes June 1988 37:749-759; doi:10.2337/diabetes.37.6.749
Induction of memory in rat pancreatic islets by tolbutamide. Dependence on ambient glucose level, calcium, and phosphoinositide
hydrolysis. Diabetes June 1988 37:816-823; doi:10.2337/diabetes.37.6.816
Induction of memory in rat pancreatic islets by tolbutamide. Dependence on ambient glucose level, calcium, and phosphoinositide
hydrolysis. Diabetes June 1988 37:816-823; doi:10.2337/diabetes.37.6.816